IT202000011056A1 - SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY - Google Patents
SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY Download PDFInfo
- Publication number
- IT202000011056A1 IT202000011056A1 IT102020000011056A IT202000011056A IT202000011056A1 IT 202000011056 A1 IT202000011056 A1 IT 202000011056A1 IT 102020000011056 A IT102020000011056 A IT 102020000011056A IT 202000011056 A IT202000011056 A IT 202000011056A IT 202000011056 A1 IT202000011056 A1 IT 202000011056A1
- Authority
- IT
- Italy
- Prior art keywords
- gel
- gel according
- weight
- alpha
- hyaluronic acid
- Prior art date
Links
- 238000011012 sanitization Methods 0.000 title claims description 18
- 230000002924 anti-infective effect Effects 0.000 title description 2
- 230000001681 protective effect Effects 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 32
- 239000000645 desinfectant Substances 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 19
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 19
- 229920002674 hyaluronan Polymers 0.000 claims description 19
- 229960003160 hyaluronic acid Drugs 0.000 claims description 19
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 239000003349 gelling agent Substances 0.000 claims description 17
- 235000011187 glycerol Nutrition 0.000 claims description 12
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 12
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 10
- 229920005862 polyol Polymers 0.000 claims description 10
- 150000003077 polyols Chemical class 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 9
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 9
- 239000003906 humectant Substances 0.000 claims description 9
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- 230000001476 alcoholic effect Effects 0.000 claims description 7
- 239000004310 lactic acid Substances 0.000 claims description 6
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 5
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 102000001708 Protein Isoforms Human genes 0.000 claims description 2
- 108010029485 Protein Isoforms Proteins 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 claims description 2
- 239000001087 glyceryl triacetate Substances 0.000 claims description 2
- 150000002334 glycols Chemical class 0.000 claims description 2
- 239000000845 maltitol Substances 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 235000010449 maltitol Nutrition 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- 125000002640 tocopherol group Chemical class 0.000 claims description 2
- 235000019149 tocopherols Nutrition 0.000 claims description 2
- 229930003802 tocotrienol Natural products 0.000 claims description 2
- 239000011731 tocotrienol Substances 0.000 claims description 2
- 229940068778 tocotrienols Drugs 0.000 claims description 2
- 235000019148 tocotrienols Nutrition 0.000 claims description 2
- 229960002622 triacetin Drugs 0.000 claims description 2
- -1 vitamin E ester Chemical class 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 239000000499 gel Substances 0.000 description 36
- 230000000694 effects Effects 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000012678 infectious agent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000000518 rheometry Methods 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- SEBPXHSZHLFWRL-UHFFFAOYSA-N 3,4-dihydro-2,2,5,7,8-pentamethyl-2h-1-benzopyran-6-ol Chemical group O1C(C)(C)CCC2=C1C(C)=C(C)C(O)=C2C SEBPXHSZHLFWRL-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
Description
DESCRIZIONE DESCRIPTION
CAMPO DELL?INVENZIONE FIELD OF THE INVENTION
La presente invenzione attiene al campo dei prodotti igienizzanti per la pelle. Si descrive una nuova formulazione di gel igienizzante, particolarmente efficace nei confronti di batteri e virus, adatta ad applicazioni ripetute e prolungate nel tempo. The present invention pertains to the field of skin sanitizing products. A new formulation of sanitizing gel is described, particularly effective against bacteria and viruses, suitable for repeated and prolonged applications over time.
STATO DELLA TECNICA STATE OF THE ART
Prodotti igienizzanti sono ampiamente utilizzati per la pulizia e disinfezione di parti della pelle, in particolare mani, che sono particolarmente esposte al contatto con agenti infettanti presenti nell?ambiente. Questi prodotti possono essere formulati in vario modo, ad es. come gel acquosi comprendenti almeno un agente disinfettante in associazione con acqua e opportuni gelificanti. Il gel diluisce il disinfettante alla concentrazione target e costituisce una fase a viscosit? medio-bassa che, rispetto a formulazioni liquide, mantiene coesione dopo l?applicazione sulla pelle, non cola o gocciola via e d? tempo all?utilizzatore di spalmare la formulazione ricoprendo tutta l?area interessata; dopo l?applicazione, la matrice gelificata forma sulla pelle un sottile film che si oppone all?evaporazione e/o dispersione delle sostanze attive antibatteriche, prolungandone l?effetto; inoltre, rispetto a creme e unguenti, l?impiego del gel ? preferito in quanto dopo essicazione il prodotto non lascia traccia percettibile sulla pelle. Sanitizing products are widely used for cleaning and disinfecting parts of the skin, especially the hands, which are particularly exposed to contact with infectious agents present in the environment. These products can be formulated in various ways, e.g. as aqueous gels comprising at least one disinfectant agent in association with water and suitable gelling agents. The gel dilutes the disinfectant to the target concentration and forms a viscosity phase. medium-low which, compared to liquid formulations, maintains cohesion after application to the skin, does not drip or drip and d? time for the user to spread the formulation covering the entire affected area; after application, the gelled matrix forms a thin film on the skin which opposes the evaporation and/or dispersion of the antibacterial active substances, prolonging their effect; moreover, compared to creams and ointments, the use of the gel? preferred because after drying the product leaves no perceptible trace on the skin.
Questi prodotti agiscono sugli infettanti ambientali gi? presenti sulla superficie corporea da trattare, inibendone crescita e vitalit?; tuttavia l?effetto pu? anche essere preventivo, contrastando in questo caso l?adesione e crescita di nuovi agenti infettanti che vengono a contatto con la pelle successivamente all?applicazione del prodotto. Come tutti i trattamenti igienizzanti, l?effetto ? transitorio e necessita di essere rinnovato nel tempo con ulteriori applicazioni di prodotto se si desidera avere una protezione lunga e duratura; l?effetto disinfettante ? inoltre diretto aspecificamente contro il materiale organico in generale, dunque pu? coinvolgere la pelle stessa causando irritazione, secchezza, ecc. Tali limitazioni non sono state normalmente percepite come problema, in quanto il gel igienizzante era normalmente utilizzato per periodi brevi in alternativa all?acqua e sapone, proteggendo l?utilizzatore durante quei particolari periodi di attivit?, ad es. outdoor, durante i quali egli non ha la possibilit? di lavare le mani in modo convenzionale. Tuttavia, la costante crescita della popolazione, la sua concentrazione nelle aree urbane, l?aumentata mobilit? delle persone ha aumentato significativamente i contatti stretti tra le persone e la possibilit? di trasmissione di vecchie e nuove malattie infettive; di conseguenza l?impiego dei prodotti igienizzanti corporei e soprattutto la loro frequenza di uso da parte del singolo utilizzatore, sono andati via via aumentando. L?uso pi? frequente ha aggravato il problema dell?aggressivit? di questi prodotti verso la pelle; per ridurre questo impatto ? possibile ridurre la concentrazione di disinfettante, ma con un?indesiderabile perdita correlata di efficacia; d?altro canto ? stato anche proposto, con modesti risultati, di aggiungere al gel sostanze dermoprotettive: tuttavia questa non ? una via facile in quanto tali sostanze possono ridurre l?efficacia del disinfettante, modificare la reologia, stabilit? o caratteri organolettici del gel, ad es. lasciare tracce fastidiose dopo applicazione che stimolano l?utilizzatore a strofinare la mano, aumentando cos? i contatti con nuove ed ulteriori quantit? di agenti infettanti. La ricerca ? dunque fortemente impegnata nella ricerca di nuove ed efficaci combinazioni di disinfettanti, gelificanti e agenti dermoprotettivi che permettano di conciliare tra loro un significativo effetto disinfettante, una reologia di gel ottimale ed un forte effetto dermoprotettivo tale da permettere un uso prolungato e frequente del prodotto, senza causare danni alla superficie della pelle interessata. L?esigenza di prodotti con questi requisiti ? sempre pi? sentita, allo scopo di contrastare e proteggersi dalla crescente diffusione di nuove malattie, in particolare quelle ad alta pericolosit? e/o alto tasso di contagio. These products act on environmental infectants already? present on the body surface to be treated, inhibiting its growth and vitality; however, the effect can? also be preventive, in this case counteracting the adhesion and growth of new infectious agents that come into contact with the skin after applying the product. Like all sanitizing treatments, the effect is? transient and needs to be renewed over time with further product applications if long-lasting protection is desired; the disinfectant effect? moreover directed aspecifically against the organic material in general, therefore pu? involve the skin itself causing irritation, dryness, etc. These limitations were not normally perceived as a problem, as the sanitizing gel was normally used for short periods as an alternative to soap and water, protecting the user during those particular periods of activity, e.g. outdoor, during which he does not have the possibility? conventional hand washing. However, the constant growth of the population, its concentration in urban areas, the increased mobility? of people has significantly increased the close contacts between people and the possibility? transmission of old and new infectious diseases; consequently the use of body sanitizing products and above all their frequency of use by the single user, have gradually increased. The use more? frequent has aggravated the problem of? aggressiveness? of these products towards the skin; to reduce this impact ? possible to reduce the disinfectant concentration, but with an undesirable correlated loss of effectiveness; on the other hand ? It has also been proposed, with modest results, to add dermoprotective substances to the gel: however this is not? an easy way as these substances can reduce the effectiveness of the disinfectant, modify the rheology, stability? o organoleptic characteristics of the gel, e.g. leave annoying traces after application that stimulate the user to rub the hand, thus increasing? contacts with new and additional quantities? of infectious agents. Research ? therefore strongly engaged in the search for new and effective combinations of disinfectants, gelling agents and dermoprotective agents which allow to reconcile a significant disinfectant effect, an optimal gel rheology and a strong dermoprotective effect such as to allow prolonged and frequent use of the product, without cause damage to the affected skin surface. The need for products with these requirements? more and more heartfelt, in order to counteract and protect themselves from the growing spread of new diseases, especially those with high danger? and/or high rate of infection.
SOMMARIO SUMMARY
La Richiedente ha ora messo a punto una nuova formulazione igienizzante che supera in modo ottimale le suddette limitazioni, conciliando una forte attivit? anti-infettiva con il pieno rispetto della fisiologia della pelle, evitando cos? le conseguenze normalmente correlate all?uso continuativo dei comuni prodotti igienizzanti, quali irritazione, secchezza ecc. La formulazione ? in forma di gel acquoso ed ? principalmente caratterizzata dal fatto di contenere un agente disinfettante alcolico e una miscela dermoprotettiva comprendente: (a) vitamina E o un suo estere, (b) acido ialuronico o un suo sale fisiologicamente accettabile e (c) uno o pi? umettanti poliolici, preferibilmente scelti tra glicerina, glicole pentilenico e/o propilene glicol. I suddetti componenti hanno dimostrato di proteggere la pelle in modo intenso e anche sinergico, senza alcun pregiudizio all?attivit? disinfettante e alle propriet? del gel: ci? permette l?applicazione ripetuta nel tempo di quantit?/concentrazioni significative di agente/i disinfettante/i senza causare danno da contatto all?area di pelle trattata. The Applicant has now developed a new sanitizing formulation which optimally overcomes the aforementioned limitations, reconciling a strong activity? anti-infective with full respect for the physiology of the skin, thus avoiding? the consequences normally related to the continuous use of common sanitizing products, such as irritation, dryness, etc. The wording? in the form of aqueous gel and ? mainly characterized in that it contains an alcoholic disinfectant agent and a dermoprotective mixture comprising: (a) vitamin E or an ester thereof, (b) hyaluronic acid or a physiologically acceptable salt thereof and (c) one or more? polyol humectants, preferably selected from glycerin, pentylene glycol and/or propylene glycol. The aforementioned components have been shown to protect the skin in an intense and even synergistic way, without any prejudice to the activity? disinfectant and properties? of the gel: there? allows the repeated application of significant quantities/concentrations of disinfectant agent(s) over time without causing contact damage to the treated skin area.
DESCRIZIONE DETTAGLIATA DELL?INVENZIONE DETAILED DESCRIPTION OF THE INVENTION
Ai sensi della presente domanda, il termine ?gel? identifica un fluido omogeneamente gelificato, comprendente uno o pi? agenti gelificanti; tale gel presenta una viscosit? dinamica preferibilmente media o bassa, in particolare compresa tra 30.000 e 100.000 mPa. According to the present application, the term ?gel? identifies a homogeneously gelled fluid, comprising one or more? gelling agents; this gel has a viscosity? preferably medium or low dynamics, in particular between 30,000 and 100,000 mPa.
Il termine ?gel igienizzante? identifica un gel come sopra definito, che include uno o pi? agenti disinfettanti alcolici. Per ?agente disinfettante? si intende, come nell?accezione comune, una sostanza in grado di uccidere batteri e/o virus. The term ?sanitizing gel? identifies a gel as defined above, which includes one or more? alcoholic disinfectant agents. For ?disinfectant agent? it means, as in the common sense, a substance capable of killing bacteria and/or viruses.
Il termine ?gel acquoso? identifica un gel come sopra definito, comprendente acqua per almeno il 18% in peso sul peso della composizione totale. The term ?aqueous gel? identifies a gel as defined above, comprising water for at least 18% by weight of the total composition.
Tutte le percentuali qui indicate, salvo diverse indicazioni, sono da intendersi come percentuali in peso sul peso totale della composizione. All the percentages indicated herein, unless otherwise indicated, are to be understood as percentages by weight on the total weight of the composition.
Il termine ?miscela dermoprotettiva? identifica e definisce l?insieme dei componenti (a) ? (c), ovvero vitamina E o un suo estere, acido ialuronico o un suo sale e un umettante poliolico; il termine, ?miscela? indica la mera co-presenza di ciascuno dei suddetti componenti all?interno del gel, senza necessariamente richiedere che essi stessi siano separatamente miscelati / pre-miscelati tra loro. Pertanto, in fase di preparazione del gel, essi saranno aggiungibili indifferentemente in forma separata o pre-miscelata tra loro, ai rimanenti componenti del gel. Detti componenti (a) ? (c) possono essere indifferentemente presenti all?interno del gel in qualsiasi forma, ad es. disciolta, sospesa, emulsionata, ecc.. Ai sensi dell?invenzione, i componenti (a) ? (c) sono sempre co-presenti; tuttavia ci? non limita le miscele all?essere tri-componenti, in quanto ciascuno di essi pu? anche essere rappresentato da pi? composti appartenenti alla stessa classe. The term ?dermoprotective mixture? identifies and defines the set of components (a) ? (c), namely vitamin E or an ester thereof, hyaluronic acid or a salt thereof and a polyol humectant; the term, ?mixture? indicates the mere co-presence of each of the aforementioned components within the gel, without necessarily requiring that they themselves are separately mixed / pre-mixed with each other. Therefore, during the preparation of the gel, they can be added indifferently in separate form or pre-mixed with each other, to the remaining components of the gel. Said components (a) ? (c) they can be indifferently present within the gel in any form, e.g. dissolved, suspended, emulsified, etc. According to the invention, the components (a) ? (c) are always co-present; however there? does not limit the mixtures to? being tri-components, as each of them can? also be represented by pi? compounds belonging to the same class.
La vitamina E o un suo estere ? il primo componente della miscela dermoprotettiva. Il termine ?Vitamina E? include tutte le forme in cui detta vitamina ? presente in natura o come derivato di sintesi: esso include dunque indifferentemente i tocoferoli, tocotrienoli, le loro miscele, le loro isoforme ?, ?, ?, ? determinate in base al numero e posizione dei gruppi metile sull?anello del cromanolo. Particolarmente preferiti ai fini dell?invenzione sono l?alfa-tocoferolo e i suoi esteri, in particolare quelli scelti dal gruppo comprendente acetato, n-propionato e linoleato, con massima preferenza per ?-tocoferil acetato. All?interno della presente miscela dermoprotettiva, la vitamina E o il suo estere esercita un utile effetto antiossidante preventivo dell?infiammazione, vantaggiosamente associato alla sua liposolubilit?, che ne favorisce l?assorbimento da parte della pelle. Vitamin E or its ester? the first component of the dermoprotective mixture. The term ?Vitamin E? includes all forms in which said vitamin ? present in nature or as a synthetic derivative: it therefore indifferently includes tocopherols, tocotrienols, their mixtures, their isoforms ?, ?, ?, ? determined based on the number and position of the methyl groups on the chromanol ring. Particularly preferred for the purposes of the invention are alpha-tocopherol and its esters, in particular those selected from the group comprising acetate, n-propionate and linoleate, with maximum preference for ?-tocopheryl acetate. Within the present dermoprotective mixture, vitamin E or its ester exerts a useful antioxidant effect that prevents inflammation, advantageously associated with its liposolubility, which favors its absorption by the skin.
L?acido ialuronico, secondo componente della miscela, ? un ben noto glucosamminoglicano di origine naturale: pu? essere utilizzato in qualsiasi forma, salificata o no, e qualunque peso molecolare (qui intesi come peso molecolare pesato o weight average molecular weight). Tra i possibili sali, ? preferito il sale sodico. Tra i pesi molecolari, sono preferiti quelli compresi tra 20 e 1000 KDa. L?acido ialuronico esercita un?attivit? dermotrofica e dermoriparativa, favorendo tra l?altro la sintesi di collagene, una proteina essenziale alla funzionalit? della pelle. Hyaluronic acid, the second component of the mixture, is a well-known glucosaminoglycan of natural origin: pu? be used in any form, salified or not, and any molecular weight (herein understood as weighted molecular weight or weight average molecular weight). Among the possible salts, ? Sodium salt preferred. Among the molecular weights, those between 20 and 1000 KDa are preferred. Hyaluronic acid exerts an activity dermotrophic and dermoriparativa, promoting among other things the synthesis of collagen, a protein essential to the functionality? of the skin.
Il terzo componente della miscela dermoprotettiva ? un umettante poliolico: questa ? una classe ben nota di prodotti che include ad esempio glicerina, triacetato di glicerile, sorbitolo, xilitolo, maltitolo, glicoli quali ad es. glicol propilenico e glicole pentilenico, polioli polimerici quali ad es. il polidestrosio , ecc. e loro miscele. Quale componente della miscela dermoprotettiva, l?umettante assicura un?adeguata idratazione, stimolando tra l?altro l?elasticit? e la funzione traspirante della pelle. The third component of the dermoprotective mixture? a polyol humectant: this? a well known class of products including for example glycerin, glyceryl triacetate, sorbitol, xylitol, maltitol, glycols such as e.g. propylene glycol and pentylene glycol, polymeric polyols such as e.g. polydextrose, etc. and mixtures thereof. As a component of the dermoprotective blend, the humectant ensures adequate hydration, among other things by stimulating skin elasticity. and the breathable function of the skin.
La Richiedente ha specificamente valutato le quantit? dei componenti (a), (b) e (c), sia tra loro all?interno della miscela dermoprotettiva che in assoluto rispetto al gel, al fine di assicurare un adeguato effetto protettivo contro l?attivit? dermoaggressiva dei composti disinfettanti presenti nel gel. Pertanto, all?interno della miscela dermoprotettiva, i suddetti componenti variano preferibilmente entro le seguenti percentuali in peso, calcolate rispetto al peso totale di (a)+(b)+(c): (a) = 30?75%, (b) = 0,5?2,5 %, (c) = 24-70%. Has the Applicant specifically evaluated the quantities? of the components (a), (b) and (c), both between them within the dermoprotective mixture and in absolute respect to the gel, in order to ensure an adequate protective effect against the activity? dermoaggressive of the disinfectant compounds present in the gel. Therefore, within the dermoprotective mixture, the above components preferably vary within the following percentages by weight, calculated with respect to the total weight of (a)+(b)+(c): (a) = 30?75%, (b ) = 0.5?2.5%, (c) = 24-70%.
In alternativa o in aggiunta, quando valutati rispetto al gel disinfettante nel suo insieme, i suddetti componenti variano preferibilmente entro le seguenti percentuali in peso, calcolate rispetto al peso totale del gel: Alternatively or in addition, when evaluated with respect to the disinfectant gel as a whole, the aforementioned components preferably vary within the following percentages by weight, calculated with respect to the total weight of the gel:
(a) : 0,5-5%, pi? preferibilmente 1-4%, ancor pi? preferibilmente 3 ? 0,5%; (a) : 0.5-5%, plus? preferably 1-4%, even more? preferably 3 ? 0.5%;
(b) : 0,05?0,5 %, pi? preferibilmente 0,07-0,3%, ancor pi? preferibilmente circa 0.1 %; (b) : 0.05?0.5%, pi? preferably 0.07-0.3%, even more? preferably about 0.1%;
(c) : 0,5?5%, pi? preferibilmente 0,7-2,5%, ancor pi? preferibilmente 0,8-2,0% (c) : 0.5?5%, plus? preferably 0.7-2.5%, even more? preferably 0.8-2.0%
La composizione del gel igienizzante dell?invenzione comprende ulteriormente l?agente disinfettante, l?agente gelificante, possibili cogelificanti, eventuali regolatori di pH, e un adeguato quantitativo di acqua utile alla formazione del gel acquoso. The composition of the sanitizing gel of the invention further comprises the disinfectant agent, the gelling agent, possible co-gelling agents, possible pH regulators, and an adequate quantity of water useful for forming the aqueous gel.
L? ?agente disinfettante?, inteso ai sensi della presente invenzione, pu? essere un singolo agente disinfettante o una combinazione di pi? agenti disinfettanti. Tale agente ? un alcanolo scelto dal gruppo comprendente etanolo, isopropanolo e loro miscele L?agente disinfettante alcolico pu? essere presente preferibilmente in quantit? in peso compresa tra 50 e 80%, pi? preferibilmente tra 65 e 75% sul peso della composizione. Quando pi? agenti disinfettanti sono usati in combinazione, le suddette percentuali si intendono riferite al totale dei disinfettanti usati. L? "disinfecting agent", understood within the meaning of the present invention, can be a single disinfectant agent or a combination of more? disinfectant agents. This agent? an alkanol selected from the group comprising ethanol, isopropanol and mixtures thereof. The alcoholic disinfectant agent can? be present preferably in quantity? by weight between 50 and 80%, pi? preferably between 65 and 75% by weight of the composition. When more? disinfectant agents are used in combination, the above percentages refer to the total number of disinfectants used.
L? ?agente gelificante?, inteso ai sensi della presente invenzione, pu? essere un singolo agente gelificante o una combinazione di pi? agenti gelificanti. L?agente gelificante ? generalmente scelto tra le idrossialchilcellulose. Tra le idrossialchilcellulose sono particolarmente preferite l?idrossietilcellulosa, l?idrossipropilcellulosa e l?idrossipropilmetilcellulosa. Il gelificante ? preferibilmente presente in quantit? in peso compresa tra 0,2 e 2% sul peso della composizione, pi? preferibilmente tra 0,5 e 1,5%. Quando pi? agenti gelificanti sono usati in combinazione, le suddette percentuali si intendono riferite al totale dei gelificanti usati. L? "gelling agent", understood within the meaning of the present invention, can be a single gelling agent or a combination of more? gelling agents. The gelling agent? generally chosen among the hydroxyalkyl celluloses. Among the hydroxyalkylcelluloses, hydroxyethylcellulose, hydroxypropylcellulose and hydroxypropylmethylcellulose are particularly preferred. The gelling agent? preferably present in quantity? by weight between 0.2 and 2% on the weight of the composition, plus? preferably between 0.5 and 1.5%. When more? gelling agents are used in combination, the above percentages refer to the total number of gelling agents used.
Il ?regolatore di pH? inteso ai sensi della presente invenzione, pu? essere un singolo regolatore di pH o una combinazione di pi? regolatori di pH. Il regolatore di pH ? un composto di natura acida o basica in grado di riportare il pH della composizione entro un intervallo di standard di sicurezza per un?applicazione topica; ad es. quando ? richiesta una correzione basica, il regolatore o correttore preferito ? un?alcanolammina quale ad es. trietanolammina; quando invece ? richiesta una correzione acida, il regolatore preferito ? un acido organico quale ad es. acido citrico o acido lattico. Il regolatore di pH pu? essere utilizzato in quantit? adatte a raggiungere il pH target, ad esempio tra 0,01 e 0,3 %. Quando pi? regolatori di pH sono usati in combinazione, le suddette percentuali si intendono riferite al totale dei regolatori di pH usati. The ?pH regulator? intended within the meaning of the present invention, pu? be a single pH regulator or a combination of pi? pH regulators. The pH regulator ? a compound of acidic or basic nature capable of bringing the pH of the composition back within a range of safety standards for topical application; e.g. when ? Basic correction required, favorite adjuster or corrector? an alkanolamine such as e.g. triethanolamine; when instead ? request an acid correction, the preferred regulator ? an organic acid such as citric acid or lactic acid. The pH regulator can? be used in quantity? suitable for reaching the target pH, for example between 0.01 and 0.3%. When more? pH regulators are used in combination, the above percentages refer to the total number of pH regulators used.
Una composizione particolarmente preferita del gel secondo la presente invenzione ? la seguente: A particularly preferred composition of the gel according to the present invention ? the following:
Alfa-tocoferil acetato 2,5-3,5% Alpha-tocopheryl acetate 2.5-3.5%
Acido ialuronico 0,05-1,5% Hyaluronic acid 0.05-1.5%
Glicerolo 1,0-2,0% Glycerol 1.0-2.0%
Etanolo 68,0-75,0% Ethanol 68.0-75.0%
Idrossietilcellulosa 0,8-1,2% Hydroxyethylcellulose 0.8-1.2%
Acido lattico 0,02-0,04% Lactic acid 0.02-0.04%
Acqua: q.b. a 100,0% Water: to taste at 100.0%
L?invenzione include inoltre un procedimento per la preparazione del suddetto gel igienizzante. Nella sua accezione pi? generale, esso prevede il passaggio di formulare, insieme ad un agente disinfettante alcolico, un agente gelificante ed acqua, una miscela dermoprotettiva comprendente vitamina E o un suo estere, acido ialuronico o un suo sale farmaceuticamente accettabile e un umettante poliolico come sopra definiti. Come sopra indicato, il termine, ?miscela dermoprotettiva? indica la mera co-presenza di ciascuno dei componenti (a), (b), (c) all?interno del gel, senza necessariamente richiedere che essi stessi vengano separatamente miscelati/pre-miscelati tra loro. Pertanto, in fase di preparazione del gel, essi saranno indifferentemente aggiungibili in forma separata o pre-miscelata tra loro, ai rimanenti componenti del gel. Pi? in generale, tutti gli ingredienti del gel possono essere aggiunti contemporaneamente o separatamente e, nell?ultimo caso, in qualsiasi sequenza. The invention also includes a process for preparing the aforementioned sanitizing gel. In its most significant sense in general, it provides for the step of formulating, together with an alcoholic disinfectant agent, a gelling agent and water, a dermoprotective mixture comprising vitamin E or an ester thereof, hyaluronic acid or a pharmaceutically acceptable salt thereof and a polyol humectant as defined above. As indicated above, the term ?dermoprotective mixture? indicates the mere co-presence of each of the components (a), (b), (c) within the gel, without necessarily requiring that they themselves are separately mixed/pre-mixed with each other. Therefore, during the preparation of the gel, they can be added indifferently in separate form or pre-mixed with each other, to the remaining components of the gel. Pi? in general, all the ingredients of the gel can be added at the same time or separately and, in the latter case, in any sequence.
L?invenzione include inoltre il gel igienizzante come sopra descritto per uso in terapia e, pi? specificamente, per l?uso in un metodo di disinfezione della pelle, in particolare per eliminare e/o prevenire contaminazioni batteriche e/o virali della pelle, con riferimento preferito ma non esclusivo, alla pelle delle mani. L?invenzione include inoltre l?uso di un gel igienizzante come sopra descritto nella preparazione di un medicamento per uso nella disinfezione della pelle, in particolare per eliminare e/o prevenire contaminazioni batteriche e/o virali della pelle, con riferimento preferito ma non esclusivo, alla pelle delle mani. L?invenzione include inoltre un metodo per eliminare e/o prevenire contaminazioni batteriche e/o virali della pelle, con riferimento preferito ma non esclusivo, alla pelle delle mani, comprendente l?applicare il gel igienizzante come sopra descritto all?area di pelle interessata di un paziente che ne ha necessit?. The invention also includes the sanitizing gel as described above for use in therapy and, more specifically, for use in a skin disinfection method, in particular for eliminating and/or preventing bacterial and/or viral contamination of the skin, with reference preferably but not exclusively to the skin of the hands. The invention also includes the use of a sanitizing gel as described above in the preparation of a medicament for use in skin disinfection, in particular to eliminate and/or prevent bacterial and/or viral contamination of the skin, with preferred but not exclusive reference to the skin of the hands. The invention also includes a method for eliminating and/or preventing bacterial and/or viral contamination of the skin, with reference, preferably but not exclusively, to the skin of the hands, comprising applying the sanitizing gel as described above to the affected skin area of a patient who needs it.
L?invenzione viene ora descritta in dettaglio e a titolo non limitativo mediante i seguenti esempi sperimentali. The invention is now described in detail and without limitation by means of the following experimental examples.
PARTE SPERIMENTALE EXPERIMENTAL PART
Sono state realizzate le seguenti composizioni in accordo con la presente invenzione. Le percentuali degli ingredienti sono espresse in peso sul peso della formulazione finale. The following compositions have been made in accordance with the present invention. The percentages of the ingredients are expressed by weight on the weight of the final formulation.
Esempio 1 Example 1
Alfa-tocoferil acetato: 3,0% Alpha-tocopheryl acetate: 3.0%
Acido ialuronico: 0,1% Hyaluronic acid: 0.1%
Glicerolo: 1,0% Glycerol: 1.0%
Etanolo: 71,5% Ethanol: 71.5%
Idrossietilcellulosa 1,0% Hydroxyethylcellulose 1.0%
Aqua: 23,4% Aqua: 23.4%
Esempio 2 Example 2
Alfa-tocoferil acetato: 3,0% Alpha-tocopheryl acetate: 3.0%
Acido ialuronico: 0,1% Hyaluronic acid: 0.1%
Glicerolo: 2,0% Glycerol: 2.0%
Etanolo: 68,6% Ethanol: 68.6%
Isopropanolo 2,9% Isopropanol 2.9%
Idrossietilcellulosa 0,8% Hydroxyethylcellulose 0.8%
Aqua: 22,6% Aqua: 22.6%
Esempio 3 Example 3
Alfa-tocoferil acetato: 3,0% Alpha-tocopheryl acetate: 3.0%
Acido ialuronico: 0,1% Hyaluronic acid: 0.1%
Glicole pentilenico: 1,88% Pentylene glycol: 1.88%
Etanolo: 75,0% Ethanol: 75.0%
Idrossipropilcellulosa 0,8% Hydroxypropylcellulose 0.8%
Aqua: 19,2% Aqua: 19.2%
Acido Citrico: 0,02 % Citric acid: 0.02%
Esempio 4 Example 4
Alfa-tocoferil acetato: 3,0% Acido ialuronico: 0,1% Glicerolo: 2,0% Etanolo: 68,6% Isopropanolo 2,9% Idrossipropilmetilcellulosa 0,8% Aqua: 22,6% Esempio 5 Alpha-tocopheryl acetate: 3.0% Hyaluronic acid: 0.1% Glycerol: 2.0% Ethanol: 68.6% Isopropanol 2.9% Hydroxypropyl methylcellulose 0.8% Aqua: 22.6% Example 5
Alfa-tocoferil linoleato: 3,0% Alpha-tocopheryl linoleate: 3.0%
Acido ialuronico: 0,1% Hyaluronic acid: 0.1%
Glicerolo: 1,0% Glycerol: 1.0%
Etanolo: 71,5% Ethanol: 71.5%
Idrossietilcellulosa 1,0% Hydroxyethylcellulose 1.0%
Aqua: 23,4% Esempio 6 Aqua: 23.4% Example 6
Alfa-tocoferil n-propionato: 3,0% Acido ialuronico: 0,1% Glicole pentilenico: 2,0% Etanolo: 75,0% Idrossipropilcellulosa 0,8% Aqua: 19,07% Acido Lattico: 0, 03 % Esempio 7 Alpha-tocopheryl n-propionate: 3.0% Hyaluronic acid: 0.1% Pentylene glycol: 2.0% Ethanol: 75.0% Hydroxypropylcellulose 0.8% Aqua: 19.07% Lactic acid: 0.03% Example 7
Alfa-tocoferil acetato: 2,5% Alpha-tocopheryl acetate: 2.5%
Acido ialuronico: 0,2% Hyaluronic acid: 0.2%
Glicerolo: 1,5% Glycerol: 1.5%
Etanolo: 71,5% Ethanol: 71.5%
Idrossietilcellulosa 1,0% Hydroxyethylcellulose 1.0%
Aqua: 23,3% Aqua: 23.3%
Esempio 8 Example 8
Alfa-tocoferil acetato: 3,0% Alpha-tocopheryl acetate: 3.0%
Acido ialuronico: 0,1% Hyaluronic acid: 0.1%
Glicerolo: 2,0% Glycerol: 2.0%
Etanolo: 71,5% Ethanol: 71.5%
Idrossietilcellulosa 0,8 % Hydroxyethylcellulose 0.8%
Aqua: 22,57% Aqua: 22.57%
Acido Lattico: 0, 03 % In prove sperimentali su volontari, il gel igienizzante in accordo con i suddetti esempi ha mostrato un significativo effetto antibatterico e antivirale. La tollerabilit? del prodotto ? stata dimostrata mediante test su volontari senza che fossero rilevabili danni evidenti alla pelle, anche dopo uso frequente e continuativo. Lactic acid: 0.03% In experimental tests on volunteers, the sanitizing gel in accordance with the aforementioned examples showed a significant antibacterial and antiviral effect. The tolerability of the product ? been demonstrated through tests on volunteers without any obvious damage to the skin being detectable, even after frequent and continuous use.
Claims (16)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102020000011056A IT202000011056A1 (en) | 2020-05-14 | 2020-05-14 | SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102020000011056A IT202000011056A1 (en) | 2020-05-14 | 2020-05-14 | SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IT202000011056A1 true IT202000011056A1 (en) | 2021-11-14 |
Family
ID=71994804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT102020000011056A IT202000011056A1 (en) | 2020-05-14 | 2020-05-14 | SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT202000011056A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003034994A2 (en) * | 2001-10-23 | 2003-05-01 | The Trustees Of Columbia University In The City Of New York | Gentle-acting skin-disinfectants and hydroalcoholic gel formulations |
| CN106074332A (en) * | 2016-06-30 | 2016-11-09 | 赖保全 | Whitening hand cream |
| CN108553387A (en) * | 2018-06-21 | 2018-09-21 | 无锡市天爱装饰工程有限公司 | A kind of three white bath foams |
| WO2018185508A1 (en) * | 2017-04-04 | 2018-10-11 | Gojo Industries Inc | Methods and compounds for increasing virucidal efficacy in hydroalcoholic systems |
-
2020
- 2020-05-14 IT IT102020000011056A patent/IT202000011056A1/en unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003034994A2 (en) * | 2001-10-23 | 2003-05-01 | The Trustees Of Columbia University In The City Of New York | Gentle-acting skin-disinfectants and hydroalcoholic gel formulations |
| CN106074332A (en) * | 2016-06-30 | 2016-11-09 | 赖保全 | Whitening hand cream |
| WO2018185508A1 (en) * | 2017-04-04 | 2018-10-11 | Gojo Industries Inc | Methods and compounds for increasing virucidal efficacy in hydroalcoholic systems |
| CN108553387A (en) * | 2018-06-21 | 2018-09-21 | 无锡市天爱装饰工程有限公司 | A kind of three white bath foams |
Non-Patent Citations (1)
| Title |
|---|
| DATABASE GNPD [online] MINTEL; 27 August 2008 (2008-08-27), ANONYMOUS: "Mira-Cuticle Reducing Complex", XP055769039, Database accession no. 963064 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7061802B2 (en) | Anti-aging composition | |
| EP2191828A1 (en) | Antifungal pharmaceutical composition | |
| WO2015002091A1 (en) | Water-soluble hyaluronic acid gel and method for producing same | |
| KR102101920B1 (en) | Cosmetic composition for improving skin condition comprising human epidermal growth factor, peptides and functional materials | |
| WO2008047680A1 (en) | External preparation for skin | |
| JP2010180213A (en) | Antiseptic microbicide, and composition for applying to human body | |
| CN112351777B (en) | Composition for external use | |
| CN106109259B (en) | A kind of shampoo shower cream preventing stink with perspiration | |
| SA112330609B1 (en) | Oral care formula | |
| KR20160044071A (en) | Preservative composition containing methyl 3-acetyl-4-hydroxybenzoate as an active ingredient | |
| KR20170122677A (en) | Composition for photo-stabilizing polydatin or pharmaceutically acceptable salt thereof | |
| KR102106212B1 (en) | hypo-allergenic manicure composition by shellac for nail and toenail and its product method | |
| JP5210527B2 (en) | Antiseptic sterilizing moisturizer and composition for external application on skin and hair | |
| IT202000011056A1 (en) | SANITIZING GEL WITH HIGH ANTI-INFECTIVE AND SKIN PROTECTIVE ACTIVITY | |
| PT1305057E (en) | COMPOSITION OF MICROPARTICULAR BIOMATERIAL FOR MEDICINAL USE | |
| KR101294092B1 (en) | Wrinkle treatment cosmetic composition with fructose 1,6-diphosphate trisodium salt | |
| ES2606233T3 (en) | Compositions for the treatment of rosacea comprising chitosan and a dicarboxylic acid amide | |
| JP6833307B2 (en) | Colored bactericidal formulation based on bispiridinium alkanes | |
| JP4734293B2 (en) | Antiseptic disinfectant and human body composition | |
| US20190343746A1 (en) | Cosmetic composition including gamma-pga as active ingredient | |
| EP3047841A1 (en) | Stability improver of aromatic compound and method for improving stability of aromatic compound | |
| US6949262B1 (en) | Skin and mucosal treatment formulation | |
| EP3226827B1 (en) | Aluminium-free antiperspirant/deodorant compositions and method of preparing the same | |
| KR20190042164A (en) | Composition and method for non-atiseptic wet tissues containing the ingredient to inhibit microbial propagation | |
| JP2001131025A (en) | Cosmetic for scalp and hair |